NCT04393519 Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2)
| NCT ID | NCT04393519 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Portal Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-05-12 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-05-12 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of non-invasive prognostic parameters in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) for complications of portal hypertension. Patients are cared according to the local standardized follow up program. Clinical and laboratory data from standard patient care are evaluated for potential prognostic value.
Eligibility Criteria
Inclusion Criteria: * Insertion of TIPS according to guidelines Exclusion Criteria: * Contraindication for TIPS
Contact & Investigator
Michael Praktiknjo, MD
PRINCIPAL INVESTIGATOR
University of Bonn
Frequently Asked Questions
Who can join the NCT04393519 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Portal Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04393519 currently recruiting?
Yes, NCT04393519 is actively recruiting participants. Contact the research team at michael.praktiknjo@ukbonn.de for enrollment information.
Where is the NCT04393519 trial being conducted?
This trial is being conducted at Bonn, Germany.
Who is sponsoring the NCT04393519 clinical trial?
NCT04393519 is sponsored by University Hospital, Bonn. The principal investigator is Michael Praktiknjo, MD at University of Bonn. The trial plans to enroll 1,000 participants.